Role of gut microbiota in liver diseases
Yasuhiro Miyake
Hepatology Research, 2013
View PDFchevron_right
Editorial: The Role of Microbiota in the Onset and Development of Intestine and Liver Diseases and Cancer: Molecular and Cell Mechanisms
Andrea quagliariello
Frontiers in Cell and Developmental Biology, 2022
View PDFchevron_right
Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
Martin Weltman
Nature Communications, 2021
View PDFchevron_right
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
alvarez mercado
Pathogens
View PDFchevron_right
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease
daniele morelli
Hepatology (Baltimore, Md.), 2018
View PDFchevron_right
Intestinal Microbiota, Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: The Potential Role of Dysbiosis in the Hepatocarcinogenesis
Giovanni Brandi
2017
View PDFchevron_right
The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer
Tuula Salo
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2016
View PDFchevron_right
Hepatocellular Cancer Induced by Infection
David Kaplan
2019
View PDFchevron_right
Early Exposure to Gut Microbiome Reduces Hepatocellular Carcinoma Risks in Mice
Hsueh-chou Lai
BioMed Research International, 2020
View PDFchevron_right
Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
Omry Koren
mSystems, 2020
View PDFchevron_right
The Association between Gut Microbiota and Intestinal Toll-like Receptors Genes Expression in Adenomatous and Colorectal Cancerous patients
meysam olfatifar
View PDFchevron_right
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis
Scott Friedman
Fibrogenesis & Tissue Repair, 2010
View PDFchevron_right
Gut-Liver Interactions in Patients with Nonalcoholic Fatty Liver Disease: Role of Intestinal Flora and Toll-like receptors
AYAT R . ABDALLAH
View PDFchevron_right
Toll-Like Receptor 4 Signaling Integrates Intestinal Inflammation with Tumorigenesis: Lessons from the Murine Model of Colitis-Associated Cancer
Yasmin Lizeth Montero Hernandez
Cancers, 2011
View PDFchevron_right
Status of bacterial colonization, Toll-like receptor expression and nuclear factor-kappa B activation in normal and diseased human livers
Stephen Strom
Clinical Immunology, 2011
View PDFchevron_right
Toll-like Receptor-6 Signaling Prevents Inflammation and Impacts Composition of the Microbiota During Inflammation-Induced Colorectal Cancer
William DePaolo
Cancer Prevention Research, 2019
View PDFchevron_right
Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma
Amedeo Amedei
HepatoBiliary Surgery and Nutrition
View PDFchevron_right
Significance of Toll-like Receptor 4 ( TLR4 )& Liver Fatty Acid-binding Protein (L-FABP) Expression in Hepatocellular Carcinoma An Immunohistochemical Study
Reda El badawy
2020
View PDFchevron_right
Distinctly altered gut microbiota in the progression of liver disease
Rosie Alegado
Oncotarget, 2016
View PDFchevron_right
Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence
Guilherme Macedo
Innate …, 2012
View PDFchevron_right
Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis
Zbigniew Z. Lewandowski
Transplantation Proceedings, 2016
View PDFchevron_right
Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
Farah Nassar
International Journal of Molecular Sciences, 2021
View PDFchevron_right
Probiotics modulated gut microbiota suppresses hepatocellular carcinoma growth in mice
Jussi Pihlajamäki
Proceedings of the National Academy of Sciences of the United States of America, 2016
View PDFchevron_right
Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma
H.p. Vasantha Rupasinghe
International Journal of Molecular Sciences, 2021
View PDFchevron_right
Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro
Chih-cheng Hsiao
Pediatric Blood & Cancer, 2013
View PDFchevron_right
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease
D. Shawcross
Alimentary Pharmacology & Therapeutics
View PDFchevron_right
The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases
Pedro Pimentel-nunes
Hepatology International, 2010
View PDFchevron_right
The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage
alvarez mercado
International Journal of Molecular Sciences, 2020
View PDFchevron_right
The intestinal microbiota and microenvironment in liver
Hong-di Ma
Autoimmunity Reviews, 2015
View PDFchevron_right